Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

EBFP Inhibitors

EBFP inhibitors are a class of chemical compounds designed to modulate the activity of EBFP (Enhanced Blue Fluorescent Protein), a genetically engineered variant of the naturally occurring Aequorea victoria green fluorescent protein (GFP). EBFP is widely used in molecular biology and bioengineering as a fluorescent marker due to its ability to emit blue light when excited by specific wavelengths. This property makes it invaluable for tracking and visualizing various biological processes in live cells, tissues, and organisms. The fluorescence of EBFP is due to its unique chromophore, a specific sequence of amino acids within the protein that absorbs and emits light. EBFP inhibitors are compounds that interfere with this fluorescent activity by altering the chromophore's structure or its surrounding environment within the protein.

The inhibition of EBFP fluorescence can occur through various mechanisms. Some inhibitors may bind directly to the chromophore, quenching its fluorescence by altering its electronic properties, thereby preventing the absorption and emission of light. Others may interact with the protein's overall structure, inducing conformational changes that either disrupt the formation of the chromophore or affect its ability to fluoresce. Additionally, certain inhibitors might act by promoting photobleaching, a process where the chromophore loses its ability to emit light over time due to prolonged exposure to excitation light. EBFP inhibitors are valuable tools in research for controlling and studying the dynamics of fluorescence in biological systems. By modulating the activity of EBFP, researchers can better understand the mechanisms that govern protein fluorescence and explore the use of fluorescence in a wide range of biological and biochemical applications.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Actinomycin D intercalates into DNA, particularly at GC-rich regions, which could lead to the transcriptional blockade of the EBFP gene, ultimately decreasing its expression.

Rifampicin

13292-46-1sc-200910
sc-200910A
sc-200910B
sc-200910C
1 g
5 g
100 g
250 g
$95.00
$322.00
$663.00
$1438.00
6
(1)

In bacterial systems, Rifampicin binds to the beta subunit of RNA polymerase, which could directly downregulate the transcription of an EBFP gene under bacterial promoters.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

α-Amanitin selectively binds to and inhibits RNA polymerase II, thus could lead to a substantial decrease in EBFP mRNA synthesis in eukaryotic cells.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$88.00
$200.00
13
(1)

Triptolide can covalently modify subunits of the transcriptional machinery, potentially leading to a sharp reduction in EBFP gene transcription.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$42.00
$185.00
$310.00
$650.00
6
(1)

DRB selectively inhibits RNA polymerase II phosphorylation, which is necessary for transcriptional elongation, potentially leading to reduced levels of EBFP mRNA.

Cordycepin

73-03-0sc-203902
10 mg
$99.00
5
(1)

Cordycepin, an adenosine analog, could terminate the transcription of EBFP prematurely, resulting in a decrease in full-length EBFP mRNA and, consequently, protein levels.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$149.00
$470.00
$620.00
$1199.00
$2090.00
33
(3)

By inhibiting histone deacetylases, Trichostatin A could induce hyperacetylation of histones, leading to a conformational change in chromatin that reduces the accessibility of the EBFP gene.

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$105.00
$408.00
$1224.00
35
(2)

Leptomycin B binds to exportin 1, necessary for nuclear export of mRNA, which could inhibit the cytoplasmic accumulation of EBFP mRNA, thereby reducing EBFP protein synthesis.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$97.00
$254.00
36
(2)

Anisomycin disrupts peptide bond formation on ribosomes, which could inhibit the translation of EBFP, resulting in a decreased production of EBFP protein.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Cycloheximide binds to the E-site of ribosomes, inhibiting the eukaryotic elongation factor eEF2, which could lead to an inhibition of EBFP protein synthesis.